Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
FDA gives Biocon biosimilars plant clean bill of health
The Biocon plant in Bangalore, India, where it manufacturers biosimilars has been issued an FDA EIR after having been cited with a Form 483 last year.
ADA: Lilly's Trulicity bests Novo's Victoza, AZ's Bydureon in real-world study
ORLANDO, Fla.
It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri
Achaogen got some anticipated good news Tuesday with an FDA nod for its high-powered antibiotic Zemdri, but it wasn't an unqualified win.
BASF shuts ibuprofen production at U.S. plant due to technical problem
FRANKFURT (Reuters) - German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said on Wednesday.
Spectrum Pharma Is Weighing a Sale
Spectrum Pharmaceuticals Inc.
Clamor for GSK shingles shot points to bigger profits
LONDON (Reuters) - GlaxoSmithKline is facing “unprecedented” demand for its new shingles vaccine Shingrix, suggesting the product could be a bigger money-spinner than the company and analy...
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy
The U.
Merrimack Announces Top-Line Results from Randomized Phase 2 Trial of MM-141 in Front-Line Metastatic Pancreatic Cancer
CAMBRIDGE, Mass.
Eye on Pharma: Lupin Announces Distribution Agreement for Etanercept Biosimilar
Lupin pharmaceuticals has entered into an agreement with Nichi-Iko for the distribution, promotion, and sale of its proposed biosimilar etanercept, YLB113, in Japan.
Researchers discover new antiviral gene that could prevent virus clone
Washington.
Dementia venture fund raises $350 million to hunt new drugs
LONDON (Reuters) - A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target of $200 million set on its launc...
Pfizer's breast cancer drug combo falls short of survival goal
(Reuters) - Pfizer Inc said on Monday a combination of its breast cancer drug, Ibrance, and another drug was not statistically significant in extending overall survival in certain patients, th...
33
34
35
36
37
38
39
40
41
